Low Dose Naltrexone for Lyme Disease: Can LDN Help Persistent Symptoms?
Low dose naltrexone may help regulate inflammation in Lyme disease
Some patients report improvements in pain, fatigue, and neurologic symptoms
LDN is generally used as part of a broader recovery strategy
Many patients with persistent Lyme disease symptoms continue searching for options after standard treatment approaches fall short.
Low dose naltrexone (LDN) has gained attention because of its potential effects on immune signaling, neuroinflammation, pain regulation, and nervous system function.
Some patients describe improvements in fatigue, widespread pain, sleep quality, sensory sensitivity, and cognitive symptoms while taking low dose naltrexone for Lyme disease.
LDN is not considered a standalone treatment for Lyme disease itself. Instead, it is typically used as part of a broader symptom management and recovery strategy.
For a broader overview of persistent symptoms and recovery approaches, visit our Persistent Lyme Disease Mechanisms hub.
What is low dose naltrexone?
Naltrexone was originally developed at much higher doses for opioid and alcohol dependence treatment.
At substantially lower doses, however, some clinicians believe the medication may temporarily block opioid receptors in ways that alter inflammatory signaling and immune regulation.
Researchers have explored low dose naltrexone in conditions involving chronic pain, neuroinflammation, autoimmune disease, and central sensitization.
Patients with Lyme disease often experience overlapping symptom patterns involving fatigue, pain amplification, sleep disruption, autonomic dysfunction, and cognitive slowing.
Why some Lyme disease patients consider LDN
Persistent Lyme disease symptoms may involve multiple overlapping mechanisms, including inflammation, autonomic dysfunction, immune dysregulation, small fiber neuropathy, and nervous system sensitization.
Some clinicians prescribe low dose naltrexone in an effort to reduce symptom amplification and improve daily function.
Patients considering LDN often report symptoms such as:
- Widespread musculoskeletal pain
- Fatigue and post-exertional worsening
- Sleep disruption
- Brain fog and slowed processing
- Sensory hypersensitivity
- Neuropathic discomfort
These symptoms may overlap with post-treatment Lyme disease syndrome and other persistent symptom presentations.
Can low dose naltrexone help inflammation?
One proposed mechanism involves modulation of microglial activation within the nervous system.
Microglia are immune-related cells in the brain and spinal cord that may contribute to neuroinflammation and symptom amplification.
Some researchers have explored whether low dose naltrexone may help calm inflammatory signaling pathways associated with chronic pain and central sensitization.
Neuroinflammation has also been discussed in patients with neurologic Lyme disease and persistent cognitive symptoms.
For more on neurologic involvement, see Neurologic Lyme disease.
What symptoms may improve with LDN?
Patient responses vary considerably.
Some patients report improvements in:
- Pain levels
- Sleep quality
- Sensory overstimulation
- Exercise tolerance
- Fatigue severity
- Mood stability
Others report little improvement or difficulty tolerating the medication.
LDN is typically introduced slowly because some patients experience temporary sleep disruption, vivid dreams, or symptom flares early in treatment.
LDN is not a cure for Lyme disease
Low dose naltrexone should not be viewed as a cure for Lyme disease or as a replacement for appropriate evaluation and treatment.
Persistent symptoms may involve ongoing infection, immune dysfunction, autonomic instability, co-infections, inflammatory injury, or overlapping chronic illness mechanisms.
Patients with air hunger, night sweats, autonomic dysfunction, or fluctuating relapses may also require evaluation for Babesia and Lyme disease and other co-infections.
Frequently Asked Questions
What is low dose naltrexone used for in Lyme disease?
Some clinicians use low dose naltrexone to help manage pain, inflammation, fatigue, sleep disruption, and neurologic symptoms associated with persistent Lyme disease presentations.
Can LDN cure Lyme disease?
No. Low dose naltrexone is generally considered a supportive therapy rather than a cure for Lyme disease.
How long does it take for LDN to work?
Some patients report improvements within weeks, while others may require several months to evaluate benefit.
Can low dose naltrexone worsen symptoms at first?
Yes. Some patients experience vivid dreams, sleep disruption, or temporary symptom worsening during dose adjustment.
Is low dose naltrexone used alone?
LDN is typically used as part of a broader treatment and recovery strategy rather than as a standalone therapy.
Clinical Takeaway
Low dose naltrexone may help some patients with persistent Lyme disease symptoms involving pain, neuroinflammation, fatigue, and nervous system dysregulation.
LDN is best viewed as one potential tool within a broader individualized Lyme disease recovery strategy.
Related Articles
Patients exploring low dose naltrexone often review additional articles involving persistent symptoms, inflammation, recovery, and nervous system dysfunction in Lyme disease.
Persistent Lyme disease
Recovery from Lyme disease
Lyme disease misdiagnosis
Lyme disease symptoms guide
Autonomic dysfunction in Lyme disease
References
- Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459.
- Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151(11):1571-1583.
- Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
- Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923-1930.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention